| Dr James Constantine Padussis, MD | |
|
Emile 42nd St, Omaha, NE 68198-0001 | |
| (402) 559-4500 | |
| (402) 559-9416 |
| Full Name | Dr James Constantine Padussis |
|---|---|
| Gender | Male |
| Speciality | Surgical Oncology |
| Experience | 19 Years |
| Location | Emile 42nd St, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457528028 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 128755 (North Carolina) | Secondary |
| 2086X0206X | Surgery - Surgical Oncology | 28765 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Great Plains Health | North platte, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unmc Physicians | 6002728391 | 1320 |
News Archive
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced today that new Phase 2b data related to ABT-450, Enanta's lead HCV protease inhibitor identified in its ongoing collaboration with AbbVie, as well as new preclinical data on Enanta's proprietary cyclophilin inhibitor, EDP-546, will be presented at the International Liver Congress, which is the 48th Annual Meeting of the European Association for the Study of the Liver taking place in Amsterdam April 24-28, 2013.
Emerus Hospital Partners, LLC, a system of Texas-based specialty hospitals, is set to expand the company's operations. Emerus Hospital Partners has obtained growth capital of $30 million from Austin Ventures, one of the nation's leading venture and growth capital firms. The capital will be used to support the company's aggressive expansion plan as well as mergers and acquisitions.
New data shows Shady Grove Fertility Center's financial programs - designed to help make infertility testing and treatment more affordable - helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.
Cognitive decline is a major concern of the aging population. Already, Alzheimer's disease affects approximately 5.4 million Americans and 30 million people globally. Without effective prevention and treatment, the prospects for the future are bleak.
› Verified 9 days ago
| Entity Name | Unmc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced today that new Phase 2b data related to ABT-450, Enanta's lead HCV protease inhibitor identified in its ongoing collaboration with AbbVie, as well as new preclinical data on Enanta's proprietary cyclophilin inhibitor, EDP-546, will be presented at the International Liver Congress, which is the 48th Annual Meeting of the European Association for the Study of the Liver taking place in Amsterdam April 24-28, 2013.
Emerus Hospital Partners, LLC, a system of Texas-based specialty hospitals, is set to expand the company's operations. Emerus Hospital Partners has obtained growth capital of $30 million from Austin Ventures, one of the nation's leading venture and growth capital firms. The capital will be used to support the company's aggressive expansion plan as well as mergers and acquisitions.
New data shows Shady Grove Fertility Center's financial programs - designed to help make infertility testing and treatment more affordable - helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.
Cognitive decline is a major concern of the aging population. Already, Alzheimer's disease affects approximately 5.4 million Americans and 30 million people globally. Without effective prevention and treatment, the prospects for the future are bleak.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Constantine Padussis, MD Emile 42nd St, Omaha, NE 68198-0001 Ph: (402) 559-4500 | Dr James Constantine Padussis, MD Emile 42nd St, Omaha, NE 68198-0001 Ph: (402) 559-4500 |
News Archive
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced today that new Phase 2b data related to ABT-450, Enanta's lead HCV protease inhibitor identified in its ongoing collaboration with AbbVie, as well as new preclinical data on Enanta's proprietary cyclophilin inhibitor, EDP-546, will be presented at the International Liver Congress, which is the 48th Annual Meeting of the European Association for the Study of the Liver taking place in Amsterdam April 24-28, 2013.
Emerus Hospital Partners, LLC, a system of Texas-based specialty hospitals, is set to expand the company's operations. Emerus Hospital Partners has obtained growth capital of $30 million from Austin Ventures, one of the nation's leading venture and growth capital firms. The capital will be used to support the company's aggressive expansion plan as well as mergers and acquisitions.
New data shows Shady Grove Fertility Center's financial programs - designed to help make infertility testing and treatment more affordable - helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.
Cognitive decline is a major concern of the aging population. Already, Alzheimer's disease affects approximately 5.4 million Americans and 30 million people globally. Without effective prevention and treatment, the prospects for the future are bleak.
› Verified 9 days ago
Bradley Hall, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 42 Nd And Emile Street Univ Of Nebraska Ctr, Department Of General Surgery, Omaha, NE 68198 Phone: 402-559-4300 Fax: 402-559-6749 | |
Dr. Brett Waibel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4017 | |
Dr. Alan T. Richards, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 8303 Dodge St, Suite # 304, Omaha, NE 68114 Phone: 402-354-5048 Fax: 402-354-2585 | |
Dr. Abbey Fingeret, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Emile 42nd St, Omaha, NE 68198 Phone: 402-559-5600 Fax: 402-559-7900 | |
Dr. John Moonkeun Park, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 515 N 162nd Ave, Ste. 300, Omaha, NE 68118 Phone: 402-393-6624 Fax: 402-393-6635 | |
Dr. John Francis Tierney Iv, MD Surgery Medicare: Medicare Enrolled Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6111 | |
Matthew Dale, MD, PHD Surgery Medicare: Medicare Enrolled Practice Location: 7710 Mercy Rd Ste 202, Omaha, NE 68124 Phone: 402-717-4900 |